NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results